Understanding the Management of HER2+, Early-Stage Breast Cancer

By The Fellow on Call - Last Updated: July 7, 2023

In this episode of The Fellow on Call: The Heme/Onc Podcast: The Fellow on Call team shifts their focus from ER+ to HER+ breast cancer.  The group details:

  • What is HER2?
  • What is the mechanism of HER2?
  • The discovery of trastuzumab
  • The use of trastuzumab in adjuvant and neoadjuvant settings
  • Highlights of key trials that shape the paradigm of management
  • And much more
Latest News

July 16, 2024